New strategies in the diagnostic and therapeutic approach to smoking.
DOI:
https://doi.org/10.35954/SM2007.29.1.7Keywords:
Patient Smoker; Smoking.Abstract
When defining smoking control strategies, it is imperative to keep in mind the true magnitude of smoking as a health risk factor, being responsible for a list of almost 50 types of diseases, including three of the four leading causes of death in our country: cardiovascular diseases, cancer and chronic respiratory diseases. The cumulative risk of early death for a smoker is 50% (i.e., one out of every two smokers will die as a result of smoking). Half of these deaths will occur in mid-life, with a loss of 20 to 25 years of life.
Downloads
References
(1) “Treating tobacco use and dependence. A Clinical Practice Guideline”. U.S. Department of Health and Human Services 2000. CDC
(2) “Evidence based recomendations on the treatment of tobacco dependence. European Partnership to reduce tobacco dependence. WHO/OMS 2001.
(3) La Epidemia de Tabaquismo. Los Gobiernos y los aspectos económicos del control del tabaco. Banco Mundial y Organización Panamericana de la Salud, 2000, Pub. Cient. N˚ 577.
(4) Organización Mundial de la Salud. Recomendaciones de políticas para dejar de fumar y tratamiento de la dependencia al consumo de tabaco. 2003.
(5) Tonstad et al. for the Varenicline Phase 3 Study Group. Effect of maintenance therapy with varenicline on smoking cessation. A randomized controlled trial. JAMA. 2006: 296:64-71.
Published
How to Cite
Issue
Section
License
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
